Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1.15B
-
Number of holders
-
477
-
Total 13F shares, excl. options
-
571M
-
Shares change
-
-5.49M
-
Total reported value, excl. options
-
$8.05B
-
Value change
-
-$17.5M
-
Put/Call ratio
-
0.69
-
Number of buys
-
235
-
Number of sells
-
-159
-
Price
-
$14.11
Significant Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q1 2024
546 filings reported holding TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share as of Q1 2024.
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) has 477 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 571M shares
of 1.15B outstanding shares and own 49.77% of the company stock.
Largest 10 shareholders include BlackRock Inc. (43.7M shares), Ion Asset Management Ltd. (38.6M shares), Phoenix Holdings Ltd. (34.6M shares), Migdal Insurance & Financial Holdings Ltd. (29.9M shares), Clal Insurance Enterprises Holdings Ltd (28.8M shares), MENORA MIVTACHIM HOLDINGS LTD. (28.1M shares), Slate Path Capital LP (26.9M shares), Lingotto Investment Management LLP (26.4M shares), FMR LLC (21.2M shares), and Rubric Capital Management LP (17.7M shares).
This table shows the top 477 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.